First, it is worth noting that there is no robust evidence this occurs in practice with current mRNA vaccine formulations. The mRNA is designed to stay in the cytoplasm, and the lipid nanoparticles do not facilitate nuclear entry. But exploring the hypothetical is valuable for understanding the underlying science.

Even if mRNA reached the nucleus, several additional barriers would need to be overcome for any meaningful genetic impact. First, the mRNA would have to cross the nuclear membrane, which is extremely rare because it lacks the specific signals needed for entry. Second, it would require a reverse transcriptase enzyme to convert the mRNA into complementary DNA. Third, that new DNA would need to insert itself into the genomic DNA, which requires either an integrase enzyme or specific DNA repair machinery to facilitate the process. Finally, for the sequence to have an effect, it would need to be expressed, which depends on the presence of specific promoter or enhancer elements nearby.

If all these unlikely steps were to occur, the most likely outcome would be silent integration. This means the DNA might insert randomly but not affect gene function, as the human genome can tolerate some non-functional insertions without consequence. However, if integration happened within an active gene, it could disrupt tumor suppressor genes, potentially creating a theoretical cancer risk, or it could activate oncogenes if inserted near regulatory regions. It could also cause loss-of-function mutations in essential genes. Additionally, foreign nucleic acids in the nucleus could trigger immune recognition, leading to DNA damage response pathways, p53 activation causing cell cycle arrest or cell death, or the activation of innate immune sensing pathways like cGAS-STING. There is also the theoretical possibility of retrotransposon activity, as human cells contain LINE-1 retrotransposons that encode reverse transcriptase. Some researchers have theorized these could convert mRNA to DNA, but LINE-1 activity is heavily suppressed in most somatic cells, and even if active, random integration is still required. To date, there is no evidence this has occurred with vaccine mRNA.

A 2022 study suggested mRNA from SARS-CoV-2 vaccines could be reverse transcribed in liver cell lines in a lab setting, but this was in cultured cells rather than living organisms, and no evidence of genomic integration was demonstrated. Subsequent studies found no evidence of integration in vaccinated individuals, and the biological relevance remains debated.

Even in this hypothetical worst-case scenario, the scale matters significantly. With billions of doses administered, there has been no signal of increased cancer or genetic disorders. Most affected cells, such as muscle and immune cells, have limited lifespans and turn over quickly. Human cells also have robust mechanisms to detect and repair foreign DNA, and there is natural selection pressure where cells with harmful mutations are likely to be eliminated.

The bottom line is that while this scenario is theoretically possible, it is practically negligible. Multiple biological barriers prevent each step of the process. However, this "can" happen, we just don't know the specifics of its action.

For more information about this science I would like to recommend to you all a book called "Turtles All The Way Down: Vaccine Science and Myth" It is long but is now available as an audio book from Audible.com

Cheers!
-warmfuzzy

--- Mystic BBS v1.12 A49 2023/04/30 (Linux/64)
* Origin: thE qUAntUm wOrmhOlE, rAmsgAtE, uK. bbs.erb.pw (700:100/37)